Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy
Gespeichert in:
| Veröffentlicht in: | AIDS patient care and STDs 2011-03, Vol.25 (3), p.131-133 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 133 |
|---|---|
| container_issue | 3 |
| container_start_page | 131 |
| container_title | AIDS patient care and STDs |
| container_volume | 25 |
| creator | García-Álvarez, Mónica Berenguer, Juan Micheloud, Dariela Guzmán-Fulgencio, María Catalán, Pilar López, Juan Carlos Cosín, Jaime Miralles, Pilar Carrero-Gras, Ana Resino, Salvador |
| description | |
| doi_str_mv | 10.1089/apc.2010.0387 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_855907476</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>855907476</sourcerecordid><originalsourceid>FETCH-LOGICAL-c292t-9b8cdadbff97b599fcd055e131799b93b82547849e13ee5e08b06de099d05a283</originalsourceid><addsrcrecordid>eNo9kc1u1TAQhS1ERUthyRZ5x6ZpnR9fe5boinIrVWJR6DZynMmtIbGDJ0Hqu_CwnaiFlT1zPh175gjxoVSXpbJw5WZ_WSmuVG3NK3FWam0K0zTwmu_KmqKCsjkVb4l-KqVspdUbcVqVFTQ7aM7E37uVFhci9vJPyGlMx-BlRppTJJQ9-oyOkCRhXic5ufwLM8k0SBePIR0xIgW6kCEOo5smt4QUL1jr5RC6nFhjSR5u7q8O-_vCJ-bQL_zYzCjGha2ifMCtWpjdb59YSS4PmN38-E6cDG4kfP9ynosf11--7w_F7bevN_vPt4WvoFoK6KzvXd8NA5hOAwy-V1pjWZcGoIO646kbYxvgFqJGZTu161EBMOcqW5-LT8--c06_V6SlnQJ5HEcXMa3UWq1BmcbsmCyeSc_DUcahnXPgrTy2pWq3PFrOo93yaLc8mP_44rx2E_b_6X8B1E-qu4nX</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>855907476</pqid></control><display><type>article</type><title>Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy</title><source>MEDLINE</source><source>Alma/SFX Local Collection</source><creator>García-Álvarez, Mónica ; Berenguer, Juan ; Micheloud, Dariela ; Guzmán-Fulgencio, María ; Catalán, Pilar ; López, Juan Carlos ; Cosín, Jaime ; Miralles, Pilar ; Carrero-Gras, Ana ; Resino, Salvador</creator><creatorcontrib>García-Álvarez, Mónica ; Berenguer, Juan ; Micheloud, Dariela ; Guzmán-Fulgencio, María ; Catalán, Pilar ; López, Juan Carlos ; Cosín, Jaime ; Miralles, Pilar ; Carrero-Gras, Ana ; Resino, Salvador</creatorcontrib><identifier>ISSN: 1087-2914</identifier><identifier>EISSN: 1557-7449</identifier><identifier>DOI: 10.1089/apc.2010.0387</identifier><identifier>PMID: 21294694</identifier><language>eng</language><publisher>United States</publisher><subject>Adult ; AIDS/HIV ; Antiviral Agents - administration & dosage ; Antiviral Agents - therapeutic use ; Biomarkers ; Drug Therapy, Combination ; Female ; Hepatitis C - complications ; Hepatitis C - virology ; HIV Infections - complications ; Humans ; Inflammation - metabolism ; Interferon-alpha - administration & dosage ; Interferon-alpha - therapeutic use ; Liver Cirrhosis - metabolism ; Male ; Middle Aged ; Neovascularization, Pathologic - metabolism ; Retrospective Studies ; Ribavirin - administration & dosage ; Ribavirin - therapeutic use</subject><ispartof>AIDS patient care and STDs, 2011-03, Vol.25 (3), p.131-133</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c292t-9b8cdadbff97b599fcd055e131799b93b82547849e13ee5e08b06de099d05a283</citedby><cites>FETCH-LOGICAL-c292t-9b8cdadbff97b599fcd055e131799b93b82547849e13ee5e08b06de099d05a283</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21294694$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>García-Álvarez, Mónica</creatorcontrib><creatorcontrib>Berenguer, Juan</creatorcontrib><creatorcontrib>Micheloud, Dariela</creatorcontrib><creatorcontrib>Guzmán-Fulgencio, María</creatorcontrib><creatorcontrib>Catalán, Pilar</creatorcontrib><creatorcontrib>López, Juan Carlos</creatorcontrib><creatorcontrib>Cosín, Jaime</creatorcontrib><creatorcontrib>Miralles, Pilar</creatorcontrib><creatorcontrib>Carrero-Gras, Ana</creatorcontrib><creatorcontrib>Resino, Salvador</creatorcontrib><title>Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy</title><title>AIDS patient care and STDs</title><addtitle>AIDS Patient Care STDS</addtitle><subject>Adult</subject><subject>AIDS/HIV</subject><subject>Antiviral Agents - administration & dosage</subject><subject>Antiviral Agents - therapeutic use</subject><subject>Biomarkers</subject><subject>Drug Therapy, Combination</subject><subject>Female</subject><subject>Hepatitis C - complications</subject><subject>Hepatitis C - virology</subject><subject>HIV Infections - complications</subject><subject>Humans</subject><subject>Inflammation - metabolism</subject><subject>Interferon-alpha - administration & dosage</subject><subject>Interferon-alpha - therapeutic use</subject><subject>Liver Cirrhosis - metabolism</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neovascularization, Pathologic - metabolism</subject><subject>Retrospective Studies</subject><subject>Ribavirin - administration & dosage</subject><subject>Ribavirin - therapeutic use</subject><issn>1087-2914</issn><issn>1557-7449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kc1u1TAQhS1ERUthyRZ5x6ZpnR9fe5boinIrVWJR6DZynMmtIbGDJ0Hqu_CwnaiFlT1zPh175gjxoVSXpbJw5WZ_WSmuVG3NK3FWam0K0zTwmu_KmqKCsjkVb4l-KqVspdUbcVqVFTQ7aM7E37uVFhci9vJPyGlMx-BlRppTJJQ9-oyOkCRhXic5ufwLM8k0SBePIR0xIgW6kCEOo5smt4QUL1jr5RC6nFhjSR5u7q8O-_vCJ-bQL_zYzCjGha2ifMCtWpjdb59YSS4PmN38-E6cDG4kfP9ynosf11--7w_F7bevN_vPt4WvoFoK6KzvXd8NA5hOAwy-V1pjWZcGoIO646kbYxvgFqJGZTu161EBMOcqW5-LT8--c06_V6SlnQJ5HEcXMa3UWq1BmcbsmCyeSc_DUcahnXPgrTy2pWq3PFrOo93yaLc8mP_44rx2E_b_6X8B1E-qu4nX</recordid><startdate>201103</startdate><enddate>201103</enddate><creator>García-Álvarez, Mónica</creator><creator>Berenguer, Juan</creator><creator>Micheloud, Dariela</creator><creator>Guzmán-Fulgencio, María</creator><creator>Catalán, Pilar</creator><creator>López, Juan Carlos</creator><creator>Cosín, Jaime</creator><creator>Miralles, Pilar</creator><creator>Carrero-Gras, Ana</creator><creator>Resino, Salvador</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201103</creationdate><title>Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy</title><author>García-Álvarez, Mónica ; Berenguer, Juan ; Micheloud, Dariela ; Guzmán-Fulgencio, María ; Catalán, Pilar ; López, Juan Carlos ; Cosín, Jaime ; Miralles, Pilar ; Carrero-Gras, Ana ; Resino, Salvador</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c292t-9b8cdadbff97b599fcd055e131799b93b82547849e13ee5e08b06de099d05a283</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Adult</topic><topic>AIDS/HIV</topic><topic>Antiviral Agents - administration & dosage</topic><topic>Antiviral Agents - therapeutic use</topic><topic>Biomarkers</topic><topic>Drug Therapy, Combination</topic><topic>Female</topic><topic>Hepatitis C - complications</topic><topic>Hepatitis C - virology</topic><topic>HIV Infections - complications</topic><topic>Humans</topic><topic>Inflammation - metabolism</topic><topic>Interferon-alpha - administration & dosage</topic><topic>Interferon-alpha - therapeutic use</topic><topic>Liver Cirrhosis - metabolism</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neovascularization, Pathologic - metabolism</topic><topic>Retrospective Studies</topic><topic>Ribavirin - administration & dosage</topic><topic>Ribavirin - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>García-Álvarez, Mónica</creatorcontrib><creatorcontrib>Berenguer, Juan</creatorcontrib><creatorcontrib>Micheloud, Dariela</creatorcontrib><creatorcontrib>Guzmán-Fulgencio, María</creatorcontrib><creatorcontrib>Catalán, Pilar</creatorcontrib><creatorcontrib>López, Juan Carlos</creatorcontrib><creatorcontrib>Cosín, Jaime</creatorcontrib><creatorcontrib>Miralles, Pilar</creatorcontrib><creatorcontrib>Carrero-Gras, Ana</creatorcontrib><creatorcontrib>Resino, Salvador</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>AIDS patient care and STDs</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>García-Álvarez, Mónica</au><au>Berenguer, Juan</au><au>Micheloud, Dariela</au><au>Guzmán-Fulgencio, María</au><au>Catalán, Pilar</au><au>López, Juan Carlos</au><au>Cosín, Jaime</au><au>Miralles, Pilar</au><au>Carrero-Gras, Ana</au><au>Resino, Salvador</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy</atitle><jtitle>AIDS patient care and STDs</jtitle><addtitle>AIDS Patient Care STDS</addtitle><date>2011-03</date><risdate>2011</risdate><volume>25</volume><issue>3</issue><spage>131</spage><epage>133</epage><pages>131-133</pages><issn>1087-2914</issn><eissn>1557-7449</eissn><cop>United States</cop><pmid>21294694</pmid><doi>10.1089/apc.2010.0387</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1087-2914 |
| ispartof | AIDS patient care and STDs, 2011-03, Vol.25 (3), p.131-133 |
| issn | 1087-2914 1557-7449 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_855907476 |
| source | MEDLINE; Alma/SFX Local Collection |
| subjects | Adult AIDS/HIV Antiviral Agents - administration & dosage Antiviral Agents - therapeutic use Biomarkers Drug Therapy, Combination Female Hepatitis C - complications Hepatitis C - virology HIV Infections - complications Humans Inflammation - metabolism Interferon-alpha - administration & dosage Interferon-alpha - therapeutic use Liver Cirrhosis - metabolism Male Middle Aged Neovascularization, Pathologic - metabolism Retrospective Studies Ribavirin - administration & dosage Ribavirin - therapeutic use |
| title | Sustained virologic response decreases serum markers of angiogenesis, inflammation, and fibrosis in HIV/HCV-coinfected patients on hepatitis C virus therapy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T17%3A49%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Sustained%20virologic%20response%20decreases%20serum%20markers%20of%20angiogenesis,%20inflammation,%20and%20fibrosis%20in%20HIV/HCV-coinfected%20patients%20on%20hepatitis%20C%20virus%20therapy&rft.jtitle=AIDS%20patient%20care%20and%20STDs&rft.au=Garc%C3%ADa-%C3%81lvarez,%20M%C3%B3nica&rft.date=2011-03&rft.volume=25&rft.issue=3&rft.spage=131&rft.epage=133&rft.pages=131-133&rft.issn=1087-2914&rft.eissn=1557-7449&rft_id=info:doi/10.1089/apc.2010.0387&rft_dat=%3Cproquest_cross%3E855907476%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=855907476&rft_id=info:pmid/21294694&rfr_iscdi=true |